CoChat

Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.

Open access
de Silva, Varuni Asanka, Suraweera, Chathurie, Ratnatunga, Suhashini S., Dayabandara, Madhubashinee, Wanniarachchi, Nimali, Hanwella, Raveen · 2016 · BMC Psychiatry

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Most antipsychotics are associated with weight gain and other metabolic complications. Several randomized trials have shown metformin to be effective, but this still hasn’t been included in clinical guidelines on managing antipsychotic induced weight gain. All double blind placebo controlled trials assessing the efficacy of metformin in the treatment of antipsychotic induced weight gain were included. Cochrane Central Register of Controlled Trials (CENTRAL) and MEDLINE were searched for the period January 2000-December 2015. Meta-analysis was carried out using the random effects model. Meta analysis of 12 published studies with a total of 743 patients found that in patients treated with antipsychotics, metformin treatment resulted in significantly better anthropometric and metabolic parameters than placebo. The mean change in weight was −3.27 kg (95 % CI −4.66 to −1.89) ( Z = 4.64, p < 0.001). Metformin compared to placebo resulted in significant reduction in BMI [−1.13 kg/m 2 (95 % CI −1.61 to −0.66)] and insulin resistance index [−1.49 (95 % CI −2.40 to −0.59)] but not fasting blood sugar [−2.48 mg/dl (95 % CI −5.54 to 0.57]. This meta-analysis confirms that metformin is effective in treating antipsychotic induced weight gain in patients with schizophrenia or schizoaffective disorder.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12888-016-1049-5

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Study flow summary
Fig. 1 Study flow summaryCC BY · PubMed Central
Fig. 2 Forest plot of difference of mean weight change of metformin versus placebo
Fig. 2 Forest plot of difference of mean weight change of metformin versus placeboCC BY · PubMed Central
Fig. 3 Forest plot of mean change in BMI in patients treated with metformin versus placebo
Fig. 3 Forest plot of mean change in BMI in patients treated with metformin versus placeboCC BY · PubMed Central
Fig. 4 Forest plot of mean change in fasting blood sugar in patients treated with metformin versus placebo
Fig. 4 Forest plot of mean change in fasting blood sugar in patients treated with metformin versus placeboCC BY · PubMed Central
Fig. 5 Forest plot of mean change in insulin resistant index in patients treated with metformin versus placebo
Fig. 5 Forest plot of mean change in insulin resistant index in patients treated with metformin versus placeboCC BY · PubMed Central
Fig. 6 Forest plot of subgroup analysis of weight change in first episode versus chronic patients
Fig. 6 Forest plot of subgroup analysis of weight change in first episode versus chronic patientsCC BY · PubMed Central
Fig. 7 Sensitivity analysis excluding ethnic Chinese patients
Fig. 7 Sensitivity analysis excluding ethnic Chinese patientsCC BY · PubMed Central
Fig. 8 Funnel plot metformin versus placebo for treatment of antipsychotic induced weight gain
Fig. 8 Funnel plot metformin versus placebo for treatment of antipsychotic induced weight gainCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. The Nordic Cochrane Centre: Review Manager (RevMan) [ComputerProgram] Version 5.0. Copenhagen: The Cochrane Collaboration, Version 5.2.6 2012.

Cited by

See all 249

Metadata

Authors
de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R.
Affiliations
  • National Hospital of Sri Lanka (LK)
  • University of Colombo (LK)
Venue
BMC Psychiatry
Published
2016-10-03
Volume
16
Issue
1
Pages
341-341
ISSN
1471-244X (ISSN-L)
OpenAlex
W2529188573
Cited by
227
References
49
Citations by year
2026: 15 · 2025: 35 · 2024: 34 · 2023: 29 · 2022: 29 · 2021: 28 · 2020: 15 · 2019: 23 · 2018: 11 · 2017: 8
FWCI
2.01
Type
journal article
Language
en
Open access
Locations
  • BMC Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
This study did not receive any specific funding
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
Keywords
metformin, antipsychotic-induced weight gain, antipsychotic drugs, schizophrenia, schizoaffective disorder, insulin resistance, body mass index, fasting blood glucose, metabolic complications, weight loss
MeSH terms
Double-Blind Method, Humans, Metformin, Psychotic Disorders, Schizophrenia, Antipsychotic Agents, Weight Gain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12888-016-1049-5
The paper
de Silva, V. A., Suraweera, C., Ratnatunga, S. S., Dayabandara, M., Wanniarachchi, N., & Hanwella, R. (2016). Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. https://doi.org/10.1186/s12888-016-1049-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.